AAVantgarde Bio
ItalyEntry
2025
Hold
1yr
Status
Active
Who owns AAVantgarde Bio?
AAVantgarde Bio is currently owned by CDP Venture Capital SGR through Large Ventures (2022 vintage), since 2025. Across its history, AAVantgarde Bio has been through 4 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
CDP Venture Capital SGRLarge Ventures · 2022 · VC
4 ownership periods · full history below
Key facts
HQItaly
SectorHealthcare / Biotech
Key takeaways
- ·Co-held by Sofinnova Partners, Athos, Neva SGR and CDP Venture Capital SGR since 2020.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2020 · present
Sofinnova PartnersActive
2020 · present(6yr) · Sofinnova Telethon · 2016 · Life Sciences VC
CDP Venture Capital SGRActive
2025 · present(1yr) · Large Ventures · 2022 · VC
Neva SGRActive
2025 · present(1yr) · Neva First · 2020 · VC
AthosActive
2025 · present(1yr) · Athos Evergreen Life Sciences · 2001 · Evergreen
More from Large Ventures
Other portfolio companies in the same fund.
Germany
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
UK
FranceTrack AAVantgarde Bio
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy AAVantgarde Bio?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on AAVantgarde Bio.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue